J. Goldman & CO LP Geron Corp Transaction History
J. Goldman & CO LP
- $3.53 Billion
- Q4 2024
A detailed history of J. Goldman & CO LP transactions in Geron Corp stock. As of the latest transaction made, J. Goldman & CO LP holds 1,669,684 shares of GERN stock, worth $2.67 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,669,684
Previous 176,239
847.4%
Holding current value
$2.67 Million
Previous $800,000
638.75%
% of portfolio
0.17%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding GERN
# of Institutions
306Shares Held
465MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$74.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$53.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$48 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$43.6 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$43.5 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $605M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...